Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

Nvidia Is Betting the Next Trillion Dollars in AI Will Come From Inference

by Team Lumida
5 hours ago
Nvidia’s Stock: Is It Too Good to Be True Now?

Key takeaways Powered by lumidawealth.com Nvidia is pivoting hard toward inference, the stage of AI where models generate responses and perform tasks in real time. Jensen Huang projected $1...

Read more

Trump Opens Second Tariff Front as White House Races to Rebuild Trade Powers

by Team Lumida
4 days ago
Trump Pushes for Greenland Acquisition, Exploring Business Deals and Military Presence

Key takeaways Powered by lumidawealth.com The US launched a second Section 301 investigation in two days, widening Trump’s tariff revival effort. This probe targets forced-labor enforcement failures across 60...

Read more

Adobe’s CEO Exit Signals AI Pressure Is Reaching the Top

by Team Lumida
4 days ago
the adobe logo on a red background

Key takeaways Powered by lumidawealth.com Adobe CEO Shantanu Narayen is stepping down, marking a major leadership shift as investors question the company’s AI positioning. The departure overshadows otherwise solid...

Read more

JPMorgan Tightens Lending to Private Credit Funds After Loan Markdowns

by Team Lumida
5 days ago
Tax-Loss Harvesting Surge: JPMorgan’s $15 Billion Windfall

Key takeaways Powered by lumidawealth.com JPMorgan restricted lending to some private credit funds after marking down the value of certain loans. The affected loans are primarily tied to software...

Read more

Costco Faces Lawsuit Over Potential Tariff Refunds

by Team Lumida
5 days ago
a building that has a sign on the side of it

Key takeaways Powered by lumidawealth.com Costco is being sued by a customer seeking tariff-related refunds. The lawsuit follows a Supreme Court ruling declaring certain Trump-era tariffs illegal. Retailers may...

Read more

Stocks Rebound as Oil Drops Below $90, but Markets Are Still Trading on Fragile Relief

by Team Lumida
6 days ago
AI Job-Loss Panic Is Running Ahead of the Data, Says Bloomberg Opinion

Key takeaways Powered by lumidawealth.com Stocks advanced as oil fell below $90, helped by reports that the IEA may pursue a record strategic reserve release. Tech led the rebound,...

Read more

Trump Family-Backed Drone Venture Seeks to Ride Pentagon’s Domestic Drone Push

by Team Lumida
1 week ago
Trump Family-Backed Drone Venture Seeks to Ride Pentagon’s Domestic Drone Push

Key takeaways Powered by lumidawealth.com Powerus is going public via reverse merger to raise capital for scaling drone manufacturing and acquisitions. The company is backed by Trump family-linked investors...

Read more

SoftBank’s $40 Billion OpenAI Loan Push Deepens Its Biggest AI Bet Yet

by Team Lumida
2 weeks ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Key takeaways Powered by lumidawealth.com SoftBank is seeking up to $40 billion in debt financing to help fund its expanding investment in OpenAI, marking its largest-ever dollar-denominated borrowing. The...

Read more

Berkshire’s Greg Abel Signals a More Active Capital Allocation Stance With Fresh Buybacks

by Team Lumida
2 weeks ago
Berkshire’s Greg Abel Signals a More Active Capital Allocation Stance With Fresh Buybacks

Key takeaways Powered by lumidawealth.com Berkshire restarted stock buybacks for the first time in nearly two years, marking an early capital-allocation signal under CEO Greg Abel. Abel personally bought...

Read more

Morgan Stanley Cuts 2,500 Jobs Despite Record Year

by Team Lumida
2 weeks ago
Morgan Stanley Q2 2024 Earnings Summary

Key takeaways Powered by lumidawealth.com Morgan Stanley is cutting ~2,500 jobs, roughly 3% of its workforce. Layoffs span investment banking & trading, wealth management, and investment management. Cuts are...

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Morgan Stanley Q2 2024 Earnings Summary

Morgan Stanley Becomes First U.S. Firm to Issue Panda Bond in China

July 25, 2025
gold and black metal tool

Gold Rebounds Above $2,900 Amid Economic Concerns and Market Volatility

March 11, 2025
Crypto to Stocks: The New Investment Shift in China

Crypto to Stocks: The New Investment Shift in China

October 7, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018